Canada markets open in 39 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.97-0.24 (-3.33%)
At close: 04:00PM EDT
6.90 -0.07 (-1.00%)
After hours: 05:08PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,290
1
60
249
4,838
Cost of Revenue
0
-
0
199
472
Gross Profit
1,290
-
60
50
4,366
Operating Expenses
Research Development
4,291
1,913
4,758
5,692
5,916
Selling General and Administrative
6,393
5,548
6,034
4,989
5,801
Total Operating Expenses
11,403
7,278
10,295
9,404
11,717
Operating Income or Loss
-10,113
-7,277
-10,235
-9,354
-7,351
Interest Expense
-
-
-
-
769
Total Other Income/Expenses Net
-96
1,703
-24
577
713
Income Before Tax
-10,180
-5,569
-10,206
-8,776
-7,407
Income from Continuing Operations
-10,180
-5,569
-10,206
-8,776
-7,407
Net Income
-10,180
-5,569
-10,206
-8,776
-18,242
Net Income available to common shareholders
-10,180
-5,569
-10,206
-8,776
-18,242
Basic EPS
-8.20
-
-15.19
-18.00
-96.60
Diluted EPS
-8.20
-
-15.19
-18.00
-96.60
Basic Average Shares
746.138
-
672
486.5
188.65
Diluted Average Shares
746.138
-
672
486.5
188.65